Annual SG&A
$13.20 M
-$2.78 M-17.38%
31 December 2023
Summary:
FSD Pharma annual selling, general & administrative expenses is currently $13.20 million, with the most recent change of -$2.78 million (-17.38%) on 31 December 2023. During the last 3 years, it has fallen by -$4.91 million (-27.09%).HUGE Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$2.44 M
+$463.29 K+23.48%
30 June 2024
Summary:
FSD Pharma quarterly selling, general & administrative expenses is currently $2.44 million, with the most recent change of +$463.29 thousand (+23.48%) on 30 June 2024. Over the past year, it has dropped by -$762.01 thousand (-23.83%).HUGE Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$637.15 M
-$7.52 M-1.19%
30 June 2024
Summary:
FSD Pharma TTM selling, general & administrative expenses is currently -$637.15 million, with the most recent change of -$7.52 million (-1.19%) on 30 June 2024. Over the past year, it has dropped by -$651.75 million (-4462.03%).HUGE TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HUGE Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.4% | -23.8% | -4462.0% |
| 3 y3 years | -27.1% | -42.5% | -3029.5% |
| 5 y5 years | -24.5% | -67.2% | -3244.9% |
HUGE Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -43.5% | -71.8% | -2599.4% |
FSD Pharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $2.44 M(+23.5%) | $9.42 M(-3.2%) |
| Mar 2024 | - | $1.97 M(+9.0%) | $9.72 M(-28.5%) |
| Dec 2023 | $13.20 M(-17.4%) | $1.81 M(-43.4%) | $13.61 M(-6.8%) |
| Sept 2023 | - | $3.20 M(+16.5%) | $14.61 M(-6.7%) |
| June 2023 | - | $2.74 M(-53.2%) | $15.65 M(-11.7%) |
| Mar 2023 | - | $5.86 M(+108.7%) | $17.73 M(+12.7%) |
| Dec 2022 | $15.98 M(-31.6%) | $2.81 M(-33.8%) | $15.73 M(-7.9%) |
| Sept 2022 | - | $4.24 M(-12.1%) | $17.09 M(+0.0%) |
| June 2022 | - | $4.83 M(+25.0%) | $17.08 M(-16.1%) |
| Mar 2022 | - | $3.86 M(-7.2%) | $20.35 M(-12.9%) |
| Dec 2021 | $23.37 M(+29.0%) | $4.16 M(-1.8%) | $23.37 M(+7.5%) |
| Sept 2021 | - | $4.24 M(-47.7%) | $21.75 M(-14.7%) |
| June 2021 | - | $8.09 M(+17.6%) | $25.49 M(+29.6%) |
| Mar 2021 | - | $6.88 M(+171.1%) | $19.67 M(+8.6%) |
| Dec 2020 | $18.11 M(-11.6%) | $2.54 M(-68.2%) | $18.11 M(-13.0%) |
| Sept 2020 | - | $7.98 M(+250.9%) | $20.81 M(+2.7%) |
| June 2020 | - | $2.27 M(-57.3%) | $20.26 M(-15.7%) |
| Mar 2020 | - | $5.32 M(+1.6%) | $24.04 M(+17.1%) |
| Dec 2019 | $20.49 M | $5.24 M(-29.5%) | $20.53 M(+1.3%) |
| Sept 2019 | - | $7.43 M(+22.8%) | $20.26 M(+33.8%) |
| June 2019 | - | $6.05 M(+235.8%) | $15.14 M(-14.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $1.80 M(-63.7%) | $17.72 M(-5.0%) |
| Dec 2018 | $17.49 M(+519.4%) | $4.97 M(+114.7%) | $18.66 M(+36.3%) |
| Sept 2018 | - | $2.32 M(-73.2%) | $13.69 M(+20.3%) |
| June 2018 | - | $8.63 M(+219.6%) | $11.38 M(+313.2%) |
| Mar 2018 | - | $2.70 M(+6806.9%) | $2.75 M(+5047.9%) |
| Feb 2018 | - | $39.10 K(+666.7%) | $53.50 K(+123.8%) |
| Dec 2017 | $2.82 M(>+9900.0%) | - | - |
| Nov 2017 | - | $5100.00(-16.4%) | $23.90 K(+21.9%) |
| Aug 2017 | - | $6100.00(+90.6%) | $19.60 K(-27.4%) |
| Aug 2017 | $19.40 K(-34.5%) | - | - |
| May 2017 | - | $3200.00(-66.3%) | $27.00 K(-13.7%) |
| Feb 2017 | - | $9500.00(+1087.5%) | $31.30 K(+43.6%) |
| Nov 2016 | - | $800.00(-94.1%) | $21.80 K(+3.8%) |
| Aug 2016 | $29.60 K(-9.8%) | $13.50 K(+80.0%) | $21.00 K(+180.0%) |
| May 2016 | - | $7500.00 | $7500.00 |
| Aug 2015 | $32.80 K(-99.7%) | - | - |
| Dec 2014 | $11.57 M(+518.3%) | - | - |
| Dec 2013 | $1.87 M(+136.7%) | - | - |
| Dec 2012 | $790.80 K(-48.2%) | - | - |
| Dec 2011 | $1.53 M(-76.5%) | - | - |
| Dec 2010 | $6.50 M(+69.6%) | - | - |
| Dec 2009 | $3.83 M | - | - |
FAQ
- What is FSD Pharma annual selling, general & administrative expenses?
- What is the all time high annual SG&A for FSD Pharma?
- What is FSD Pharma annual SG&A year-on-year change?
- What is FSD Pharma quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for FSD Pharma?
- What is FSD Pharma quarterly SG&A year-on-year change?
- What is FSD Pharma TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for FSD Pharma?
- What is FSD Pharma TTM SG&A year-on-year change?
What is FSD Pharma annual selling, general & administrative expenses?
The current annual SG&A of HUGE is $13.20 M
What is the all time high annual SG&A for FSD Pharma?
FSD Pharma all-time high annual selling, general & administrative expenses is $23.37 M
What is FSD Pharma annual SG&A year-on-year change?
Over the past year, HUGE annual selling, general & administrative expenses has changed by -$2.78 M (-17.38%)
What is FSD Pharma quarterly selling, general & administrative expenses?
The current quarterly SG&A of HUGE is $2.44 M
What is the all time high quarterly SG&A for FSD Pharma?
FSD Pharma all-time high quarterly selling, general & administrative expenses is $8.63 M
What is FSD Pharma quarterly SG&A year-on-year change?
Over the past year, HUGE quarterly selling, general & administrative expenses has changed by -$762.01 K (-23.83%)
What is FSD Pharma TTM selling, general & administrative expenses?
The current TTM SG&A of HUGE is -$637.15 M
What is the all time high TTM SG&A for FSD Pharma?
FSD Pharma all-time high TTM selling, general & administrative expenses is $25.49 M
What is FSD Pharma TTM SG&A year-on-year change?
Over the past year, HUGE TTM selling, general & administrative expenses has changed by -$651.75 M (-4462.03%)